Skip to main content
. 2024 May 6;14:10324. doi: 10.1038/s41598-024-61133-z

Figure 2.

Figure 2

Cytokine and chemokine analysis of patients in the PM and MS groups during the mild stage of COVID-19, (A) Schematic diagram illustrating patients in the PM and MS groups. (BH) Differences in the expression of IL-3, IL-12 (p40), IL-9, IL-17, LIF, HGF, and β-NGF between patients in the PM and MS groups during the initial mild phase of COVID-19. The p value was calculated using unpaired two-sided Student’s t tests. *P < 0.05, **P < 0.01.